Differential modulation of cytokine production by drugs: implications for therapy in heart failure. [electronic resource]
Producer: 19970325Description: 2491-9 p. digitalISSN:- 0022-2828
- 3',5'-Cyclic-AMP Phosphodiesterases -- antagonists & inhibitors
- 3',5'-Cyclic-GMP Phosphodiesterases
- 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone -- pharmacology
- 8-Bromo Cyclic Adenosine Monophosphate -- pharmacology
- Amrinone -- pharmacology
- Cells, Cultured
- Cyclic GMP -- analogs & derivatives
- Cyclic Nucleotide Phosphodiesterases, Type 3
- Cyclic Nucleotide Phosphodiesterases, Type 4
- Cyclic Nucleotide Phosphodiesterases, Type 5
- Heart Failure -- therapy
- Humans
- Interleukin-1 -- biosynthesis
- Interleukin-6 -- biosynthesis
- Kinetics
- Leukocytes, Mononuclear -- cytology
- Lipopolysaccharides -- pharmacology
- Phosphodiesterase Inhibitors -- pharmacology
- Phosphoric Diester Hydrolases
- Piperidines -- pharmacology
- Pyrazines
- Pyridazines -- pharmacology
- Quinazolines -- pharmacology
- Quinolines -- pharmacology
- Tumor Necrosis Factor-alpha -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.